StockData

ANI Pharmaceuticals vs Insmed

ANIP and INSM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ANIP and INSM compare

Insmed is the larger company, worth 17 times as much as ANI Pharmaceuticals ($26.7B against $1.6B).

Insmed grew revenue faster over the last twelve months (240% versus 30.9% for ANI Pharmaceuticals).

ANI Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of 11.1% compared with −39.9% at Insmed.

ANI Pharmaceuticals scores higher on the StockData Score (14 against 8 for Insmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricANIPINSM
Size and price
Market cap$1.6B$26.7B
Share price$69.99$121.86
Change, 1 year−16.7%−36.9%
Change, 5 years71.7%321%
Beta (5Y)0.650.84
Employees9701,664
StockData Score
Total score14 (better)8
Valuation score5 (better)0
Growth score23 (better)
Performance score4 (better)2
Health score33
Dividend score00
Valuation
P/E14.9×–
P/S1.6× (better)17.6×
P/B2.7× (better)36.8×
EV/EBITDA6.6×–
P/FCF9.3×–
FCF yield10.8% (better)−2.3%
Fair value$133.72$61.10
Margin of safety47.7% (better)−99.5%
Growth
Revenue growth (TTM)30.9%240% (better)
Revenue growth, 5Y average33.5% (better)29.8%
Profitability
Gross margin60.4%84.4% (better)
Operating margin15.4% (better)−37.1%
Net margin11.1% (better)−39.9%
FCF margin17.7% (better)−41.3%
Return on equity21.0% (better)−72.5%
Return on invested capital21.3%–
Financial health
Debt / equity0.50 (better)0.76
Net debt / EBITDA−0.25–
Interest coverage4.8× (better)−6.9×
Current ratio2.91 (better)2.86
Altman Z-score2.537.42 (better)
Piotroski F-score7 (better)4
Dividends and buybacks
Payout ratio0.32%–
Buyback yield1.4%–
Shareholder yield1.4% (better)0.00%
Ownership
Held by institutions100%102%
Held by insiders12.3%0.89%
Insider net buying, 12 months−$13.6M (better)−$133M
Superinvestors holding–1
Short interest, % of float17.8%6.5%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.